Category: Uncategorised
Pharmanovia acquires exclusive rights to treatment for Parkinson’s disease
More information
New Pharmanovia study results reveal chloral hydrate noticeably improves severe insomnia within two weeks
More information
Pharmanovia partners with Echo Therapeutics for promotional activities in Australia
More information
Global pharmaceutical leader sets sight on sustainable future for the sector by setting challenging SBTI Net Zero target
More information
Pharmanovia enters new chemical entity licensing agreement with Stealth BioTherapeutics to market and further develop a potential novel treatment for Barth Syndrome
More information